A5053853378- Nanoparticle-Based Drug Delivery
- Nanoplatforms for cancer theranostics
- MicroRNA in disease regulation
- Cancer Mechanisms and Therapy
- Colorectal Cancer Surgical Treatments
- Monoclonal and Polyclonal Antibodies Research
- Advanced Biosensing Techniques and Applications
- Colorectal and Anal Carcinomas
- Microencapsulation and Drying Processes
- 3D Printing in Biomedical Research
- Microbial Inactivation Methods
- Reproductive System and Pregnancy
- Advancements in Transdermal Drug Delivery
- Advanced biosensing and bioanalysis techniques
- Wound Healing and Treatments
- Peptidase Inhibition and Analysis
- Pregnancy and preeclampsia studies
- Graphene and Nanomaterials Applications
- Bioactive Compounds and Antitumor Agents
- Proteins in Food Systems
Shandong University
2019-2021
Shanxi Medical University
2019-2020
Thymosin β-4(Tβ-4) is a macromolecular protein drug with potential for development in wound repair but limited by the shortcomings of protein, such as large volumes, poor membrane permeability, and unstable physicochemical characteristics. Ethosomes could enhance cell fluidity reduce epidermal density to make drugs through stratum corneum into deeper layers skin easily. Herein, we developed characterized novel transdermal delivery vehicle load peptides use Tβ-4 model wrapped ethosomes.We...
Differential expression of microRNA (miR)‑335‑5p, a key tumor suppressor, has been detected in pre‑eclampsia (PE) placentas. However, the role miR‑335‑5p pathogenesis PE and factor modulating its aberrant remain unknown. The present study used JEG‑3 cells vitro to investigate these mechanisms. proliferation, apoptosis migration was investigated using MTT, Annexin V‑FITC/PI, Transwell wound healing assays, respectively. levels were analyzed reverse transcription‑quantitative PCR. E‑cadherin,...